BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
49.08
-1.15 (-2.29%)
At close: Aug 22, 2025, 4:00 PM
49.60
+0.52 (1.06%)
After-hours: Aug 22, 2025, 7:32 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $9.38 billion as of August 22, 2025. Its market cap has increased by 108.61% in one year.
Market Cap
9.38B
Enterprise Value
10.48B
1-Year Change
108.61%
Ranking
Category
Stock Price
$49.08
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $9.38B, an increase of 182.63%. That is a compound annual growth rate of 18.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 9.38B | 80.92% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | 8.72B | 101.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |